Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer.

Sally J DeNardo; Carol M Richman; Huguette Albrecht; Patricia A Burke; Arut Natarajan; Aina Yuan; Jeff P Gregg; R T O'Donnell; Gerald L DeNardo

doi:10.1158/1078-0432.CCR-1004-0013

Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer.

Identifier:nobleid.org/w1/20260515/014CD2ED

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/014CD2ED.svg?ark=w1%2F20260515%2F014CD2ED)](https://nobleid.org/work/w1/20260515/014CD2ED)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer.

Identifier:nobleid.org/w1/20260515/014CD2ED

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/014CD2ED.svg?ark=w1%2F20260515%2F014CD2ED)](https://nobleid.org/work/w1/20260515/014CD2ED)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work